Sequoia Financial Advisors LLC Buys 5,620 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

Sequoia Financial Advisors LLC raised its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 5.9% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 100,191 shares of the medical research company’s stock after buying an additional 5,620 shares during the period. Sequoia Financial Advisors LLC’s holdings in Thermo Fisher Scientific were worth $49,855,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in TMO. Kavar Capital Partners Group LLC raised its position in shares of Thermo Fisher Scientific by 1.5% in the 1st quarter. Kavar Capital Partners Group LLC now owns 29,305 shares of the medical research company’s stock valued at $14,582,000 after acquiring an additional 425 shares during the period. Pure Financial Advisors LLC raised its position in shares of Thermo Fisher Scientific by 2.4% in the 1st quarter. Pure Financial Advisors LLC now owns 1,144 shares of the medical research company’s stock valued at $569,000 after acquiring an additional 27 shares during the period. Omnia Family Wealth LLC acquired a new stake in shares of Thermo Fisher Scientific in the 1st quarter valued at approximately $208,000. New World Advisors LLC raised its position in shares of Thermo Fisher Scientific by 13.1% in the 1st quarter. New World Advisors LLC now owns 1,353 shares of the medical research company’s stock valued at $673,000 after acquiring an additional 157 shares during the period. Finally, Tyche Wealth Partners LLC raised its position in shares of Thermo Fisher Scientific by 1.2% in the 1st quarter. Tyche Wealth Partners LLC now owns 2,364 shares of the medical research company’s stock valued at $1,176,000 after acquiring an additional 27 shares during the period. Institutional investors own 89.23% of the company’s stock.

Insiders Place Their Bets

In other Thermo Fisher Scientific news, EVP Gianluca Pettiti sold 300 shares of the business’s stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $429.93, for a total transaction of $128,979.00. Following the transaction, the executive vice president now owns 23,167 shares of the company’s stock, valued at $9,960,188.31. The trade was a 1.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

TMO has been the topic of a number of analyst reports. Wall Street Zen upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating in a research report on Wednesday, May 21st. Stifel Nicolaus lowered their target price on Thermo Fisher Scientific from $665.00 to $620.00 and set a “buy” rating for the company in a research note on Thursday, April 24th. Scotiabank cut their price target on shares of Thermo Fisher Scientific from $650.00 to $605.00 and set a “sector perform” rating on the stock in a research note on Friday, April 25th. Robert W. Baird lowered their price objective on shares of Thermo Fisher Scientific from $603.00 to $573.00 and set an “outperform” rating for the company in a research report on Thursday, April 24th. Finally, The Goldman Sachs Group set a $610.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Wednesday, April 23rd. Four analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $604.05.

Thermo Fisher Scientific Price Performance

NYSE:TMO opened at $410.45 on Thursday. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.38 and a current ratio of 1.77. The stock’s 50-day simple moving average is $410.39 and its 200 day simple moving average is $485.33. The company has a market cap of $154.94 billion, a P/E ratio of 24.07, a P/E/G ratio of 2.13 and a beta of 0.78. Thermo Fisher Scientific Inc. has a 52-week low of $385.46 and a 52-week high of $627.88.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, April 23rd. The medical research company reported $5.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.10 by $0.05. The business had revenue of $10.36 billion for the quarter, compared to the consensus estimate of $10.23 billion. Thermo Fisher Scientific had a return on equity of 17.15% and a net margin of 15.19%. Thermo Fisher Scientific’s quarterly revenue was up .2% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.11 earnings per share. As a group, sell-side analysts forecast that Thermo Fisher Scientific Inc. will post 23.28 EPS for the current fiscal year.

Thermo Fisher Scientific Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Friday, June 13th will be given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 0.42%. The ex-dividend date is Friday, June 13th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 10.09%.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.